Sanders Morris Harris’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,073
| Closed | -$28.6K | – | 210 |
|
|
2025
Q1 | $28.6K | Buy |
20,073
+8,973
| +81% | +$12.8K | ﹤0.01% | 278 |
|
|
2024
Q4 | $24.4K | Buy |
+11,100
| New | +$24.4K | ﹤0.01% | 283 |
|
|
2022
Q4 | – | Sell |
-12,200
| Closed | -$80K | – | 224 |
|
|
2022
Q3 | $80K | Hold |
12,200
| – | – | 0.02% | 277 |
|
|
2022
Q2 | $79K | Sell |
12,200
-12,200
| -50% | -$79K | 0.02% | 276 |
|
|
2022
Q1 | $113K | Buy |
24,400
+12,200
| +100% | +$56.5K | 0.02% | 286 |
|
|
2021
Q4 | $63K | Hold |
12,200
| – | – | 0.01% | 302 |
|
|
2021
Q3 | $125K | Hold |
12,200
| – | – | 0.02% | 297 |
|
|
2021
Q2 | $242K | Hold |
12,200
| – | – | 0.05% | 267 |
|
|
2021
Q1 | $336K | Hold |
12,200
| – | – | 0.07% | 208 |
|
|
2020
Q4 | $328K | Buy |
+12,200
| New | +$328K | 0.07% | 216 |
|